Evidence map›Paper›PMID 35036773›Full record

ArticleACS omega2022

Atomistic Model of Solute Transport across the Blood-Brain Barrier.

Christian Jorgensen, Martin B Ulmschneider, Peter C Searson

Abstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Guidelines for Comparing Circular Dichroism Spectroscopy and Molecular Dynamics Simulations for Biomolecules.Chemphyschem : a European journal of chemical physics and physical chemistry · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Permeability Benchmarking: Guidelines for ComparingJournal of chemical information and modeling · 2025
    Review
  9. Review
  10. Article
  11. Acoustofluidic Engineering of Functional Vessel-on-a-Chip.ACS biomaterials science & engineering · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted Pharmaceutics.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christian JorgensenInstitute for Nanobiotechnology, Johns Hopkins University, Baltimore, Maryland 21218, United States.
Martin B UlmschneiderDepartment of Chemistry, King's College, London WC2R 2LS, U.K.
Peter C SearsonInstitute for Nanobiotechnology, Johns Hopkins University, Baltimore, Maryland 21218, United States.ORCID https://orcid.org/0000-0002-5417-0828

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The blood-brain barrier remains a major roadblock to the delivery of drugs to the brain. While

Identifiers

PMID35036773
PMCPMC8757349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.